OCUL
Ocular Therapeutix, Inc. · Healthcare
President and CEO Antony C. Mattessich sold $83K of Ocular Therapeutix, Inc.
Sold$83,397
$4.24Price
19,669Shares
−4%Stake
What OCUL did after the filing
- The stock from Wed, Feb 8 close, $4.10
- +20.0%
- S&P 500, same days
- −3.9%
Measured over 30 trading days, to the Mar 23 close.
Traded Mon, Feb 6. Filed Wed, Feb 8, 2:29 PM ET, during the session. Returns use the Feb 8 close and the Mar 23 close. Not investment advice.